CBS 2019
CBSMD教育中心
English

推荐文献

科研文章

荐读文献

Appropriate Use Criteria and Health Status Outcomes Following Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From the OPEN-CTO Registry Guidelines in review: Comparison of the 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes and the 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation Frequency, Regional Variation, and Predictors of Undetermined Cause of Death in Cardiometabolic Clinical Trials: A Pooled Analysis of 9259 Deaths in 9 Trials Variation in Revascularization Practice and Outcomes in Asymptomatic Stable Ischemic Heart Disease 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Coronary Artery Calcium Progression Is Associated With Coronary Plaque Volume Progression - Results From a Quantitative Semiautomated Coronary Artery Plaque Analysis The year in cardiovascular medicine 2020: interventional cardiology Mortality 10 Years After Percutaneous or Surgical Revascularization in Patients With Total Coronary Artery Occlusions Sudden Cardiac Arrest Survivorship: A Scientific Statement From the American Heart Association Guiding Principles for Chronic Total Occlusion Percutaneous Coronary Intervention

GuidelineACC/AHA Clinical Practice Guidelines; angioedema; angiotensin receptor blockers; angiotensin receptor-neprilysin inhibitor; angiotensin-converting enzyme inhibitors; beta blockers; focused update; hea

JOURNAL:Eur Heart J. Article Link

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

Ponikowski P, Voors AA, ESC Scientific Document Group. et al. Keywords: Arrhythmias; Cardiac resynchronization therapy; Co-morbidities; Diagnosis; Ejection fraction; Guidelines; Heart failure; Hospitalization; Mechanical circulatory support; Multidisciplinary management; Natriuretic peptides; Neuro-hormonal antagonists; Pharmacotherapy; Transplantation

Full Text PDF